e-learning
resources
Munich 2006
Monday 04.09.2006
The different flavours of tobacco control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cell profile in bronchoalveolar lavage (BAL) and function testing in narghile (waterpipe) smokers
B. Ourari, A. Zouaoui, N. Mehiri, J. Cherif, S. Khalsi, E. Enaifer, J. Daghfous, B. Louzir, S. Boubaker, M. Beji (Tunis, Tunisia)
Source:
Annual Congress 2006 - The different flavours of tobacco control
Session:
The different flavours of tobacco control
Session type:
Thematic Poster Session
Number:
2699
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Ourari, A. Zouaoui, N. Mehiri, J. Cherif, S. Khalsi, E. Enaifer, J. Daghfous, B. Louzir, S. Boubaker, M. Beji (Tunis, Tunisia). Cell profile in bronchoalveolar lavage (BAL) and function testing in narghile (waterpipe) smokers. Eur Respir J 2006; 28: Suppl. 50, 2699
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Altered microRNA profiles in the bronchoalveolar lavage fluid exosomes in asthma and COPD
Related content which might interest you:
Bronchoalveolar lavage in COPD, smokers and non-smokers: inflammatory cells and macrophage phenotype
Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD
Year: 2004
Gender differences in 5- and 12/15-lipoxygenases products in bronchoalveolar lavage fluid from healthy never-smokers, smoker and COPD patients
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Expression of Fas antigen on bronchoalveolar lavage cells in sarcoidosis- differences between smokers and nonsmokers
Source: Eur Respir J 2003; 22: Suppl. 45, 177s
Year: 2003
Sputum rather than bronchoalveolar lavage (BAL) cells are associated with small airways function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 198s
Year: 2002
Analysis of bronchoalveolar lavage (BAL) proteins in metsovites environmentally exposed to asbestos
Source: Annual Congress 2007 - Experimental and observational studies with environmental agents
Year: 2007
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Experiences with bronchoalveolar lavage (BAL) in children
Source: Eur Respir J 2004; 24: Suppl. 48, 399s
Year: 2004
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Workstation 2: How to process bronchoalveolar lavage (BAL)
Source: International Congress 2015 – EW2 Research bronchoscopies
Year: 2015
Workstation 2: How to process bronchoalveolar lavage (BAL)
Source: International Congress 2015 – EW6 Research bronchoscopies
Year: 2015
Workstation 2: How to process bronchoalveolar lavage (BAL)
Source: International Congress 2015 – EW4 Research bronchoscopies
Year: 2015
Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007
Biochemical markers in bronchoalveolar lavage (BAL)
Source: Eur Respir J 2001; 18: Suppl. 33, 385s
Year: 2001
Broncho-alveolar lavage (BAL) at asymptomatic subjects with professional exposure to asbestos fibers
Source: Eur Respir J 2003; 22: Suppl. 45, 185s
Year: 2003
Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006
Markers of fibrosis in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) in sarcoidosis
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
The contribution of iron-laden macrophages in bronchoalveolar lavage (BAL) in the diagnostic assessment of asbestos-exposed workers
Source: Eur Respir J 2001; 18: Suppl. 33, 532s
Year: 2001
Wood smoke exposure induces the activation of bronchoalveolar lavage lymphocytes
Source: International Congress 2019 – Air pollution and the lungs
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept